Logo
Whalesbook
HomeStocksNewsPremiumAbout UsContact Us

Goldman Sachs REVEALS Maruti Suzuki's Next Big Move: Top Pick with Stunning ₹19,000 Target!

Auto|5th December 2025, 2:55 AM
Logo
AuthorAditi Singh | Whalesbook News Team

Overview

Goldman Sachs has added Maruti Suzuki India to its Asia Pacific conviction list, reiterating a 'Buy' rating and a ₹19,000 target price, projecting a 19% upside. The brokerage cited improving small car demand, a favorable product cycle with new launches like Victoris and eVitara, and anticipated volume growth. Maruti Suzuki also reported strong November sales, exceeding expectations with a 26% year-on-year increase.

Goldman Sachs REVEALS Maruti Suzuki's Next Big Move: Top Pick with Stunning ₹19,000 Target!

Stocks Mentioned

Maruti Suzuki India Limited

Maruti Suzuki India Ltd. shares are poised to attract investor attention following a significant endorsement from global brokerage Goldman Sachs. The financial giant has included the country's largest passenger vehicle maker in its prestigious Asia Pacific conviction list, underscoring strong confidence in its future prospects.

Goldman Sachs Upgrade

  • Goldman Sachs has reaffirmed its 'Buy' recommendation for Maruti Suzuki India.
  • The brokerage has set an ambitious target price of ₹19,000 per share.
  • This target suggests a potential upside of approximately 19% from the stock's recent closing price.
  • Inclusion in the Asia Pacific conviction list indicates a high level of conviction from the global firm.

Key Reasons for Optimism

  • Goldman Sachs pointed to an improving demand elasticity in the crucial small car segment.
  • The company is entering what the brokerage anticipates will be a favorable product cycle.
  • Potential shifts in consumer behavior are expected, with post-GST price actions in entry-level models and compact SUVs potentially drawing customers from the two-wheeler market.
  • Upcoming model launches, including the Victoris and eVitara, are key catalysts.
  • These new vehicles are projected to lift Maruti Suzuki's overall volumes by around 6% in FY27 when compared to FY25.
  • Additional tailwinds identified include the next pay commission cycle expected in FY28 and Maruti's strategic positioning concerning CO₂ efficiency.

Strong November Sales Performance

  • Maruti Suzuki reported robust total sales figures for November, selling 2.29 lakh units.
  • This performance surpassed the CNBC-TV18 poll estimate of 2.13 lakh units.
  • The total sales represent a significant year-on-year growth of 26%, up from 1.82 lakh units in November of the previous year.
  • Domestic sales stood at 1.83 lakh units, marking a 19.7% increase compared to 1.53 lakh units in the year-ago period.
  • The company also witnessed a substantial surge in exports, with total exports rising by 61% to 46,057 units from 28,633 units in the prior year.

Analyst Consensus

  • Maruti Suzuki enjoys widespread support among analysts covering the stock.
  • Out of 48 analysts with coverage, a commanding 41 recommend a 'Buy' rating.
  • Five analysts suggest holding the stock, while only two have issued a 'Sell' recommendation.

Stock Performance

  • Maruti Suzuki India Ltd. shares closed 0.64% lower on Thursday, at ₹15,979.
  • Despite the minor recent dip, the stock has delivered strong returns in 2025, gaining over 42% year-to-date.

Impact

  • The strong endorsement from Goldman Sachs, coupled with a reiterated 'Buy' rating and an elevated target price, is expected to bolster investor confidence in Maruti Suzuki.
  • This positive sentiment, backed by robust sales figures and a favorable analyst consensus, could translate into upward price movement for the stock.
  • The news may also influence investor sentiment towards other automotive stocks in the Indian market, highlighting potential growth opportunities within the sector.
  • Impact Rating: 8

Difficult Terms Explained

  • Asia Pacific conviction list: A selection of stocks that a brokerage firm has very high confidence in, expecting them to significantly outperform in the Asia-Pacific region.
  • 'Buy' recommendation: An investment rating suggesting that investors should purchase the stock.
  • Target price: The price level at which an analyst or brokerage expects a stock to trade within a specified timeframe, based on their valuation.
  • Demand elasticity: A measure of how sensitive the quantity demanded of a good or service is to a change in its price.
  • Product cycle: The sequence of stages a product goes through from its introduction to the market, through growth and maturity, to decline.
  • GST: Goods and Services Tax, a comprehensive indirect tax levied on the supply of goods and services in India.
  • CO₂ efficiency: A metric indicating how much carbon dioxide a vehicle emits relative to its performance, such as per kilometer driven or per liter of fuel consumed.

No stocks found.


Tech Sector

Infosys Stock Tumbles 15% YTD: Can AI Strategy and Favorable Valuation Spark a Turnaround?

Infosys Stock Tumbles 15% YTD: Can AI Strategy and Favorable Valuation Spark a Turnaround?

China's AI Chip Giant Moore Threads IPO EXPLODES Over 500% On Debut – Is This the Next Big Tech Boom?

China's AI Chip Giant Moore Threads IPO EXPLODES Over 500% On Debut – Is This the Next Big Tech Boom?

China's Nvidia Challenger EXPLODES 500% on IPO Day! AI Chip Race Heats Up!

China's Nvidia Challenger EXPLODES 500% on IPO Day! AI Chip Race Heats Up!

Crypto's Future Revealed: 2026 When AI & Stablecoins Will Forge a New Global Economy, VC Hashed Predicts!

Crypto's Future Revealed: 2026 When AI & Stablecoins Will Forge a New Global Economy, VC Hashed Predicts!

Apple Lures Meta Legal Chief Jennifer Newstead: iPhone Giant's Major Executive Overhaul!

Apple Lures Meta Legal Chief Jennifer Newstead: iPhone Giant's Major Executive Overhaul!


Brokerage Reports Sector

BSE Stock Set for Massive Surge? Brokerage Initiates 'Buy' With Groundbreaking Target Price!

BSE Stock Set for Massive Surge? Brokerage Initiates 'Buy' With Groundbreaking Target Price!

Bajaj Broking's Top Stock Bets REVEALED! Max Healthcare & Tata Power: Buy Signals Issued, Nifty/Bank Nifty Forecast!

Bajaj Broking's Top Stock Bets REVEALED! Max Healthcare & Tata Power: Buy Signals Issued, Nifty/Bank Nifty Forecast!

HDFC Securities Drops CONCOR Options Bomb: Massive Profit Potential Unlocked! See Strategy Now!

HDFC Securities Drops CONCOR Options Bomb: Massive Profit Potential Unlocked! See Strategy Now!

GET INSTANT STOCK ALERTS ON WHATSAPP FOR YOUR PORTFOLIO STOCKS
applegoogle
applegoogle

More from Auto

Shocking Acquisition! Shriram Pistons & Rings Stock Skyrockets Near Record High After Major Deal!

Auto

Shocking Acquisition! Shriram Pistons & Rings Stock Skyrockets Near Record High After Major Deal!

Shriram Pistons Mega Deal: Acquires Grupo Antolin India For ₹1,670 Crore - Investor Alert!

Auto

Shriram Pistons Mega Deal: Acquires Grupo Antolin India For ₹1,670 Crore - Investor Alert!

Goldman Sachs REVEALS Maruti Suzuki's Next Big Move: Top Pick with Stunning ₹19,000 Target!

Auto

Goldman Sachs REVEALS Maruti Suzuki's Next Big Move: Top Pick with Stunning ₹19,000 Target!

⚡️ $45 Million EV Power-Up! Ultraviolette's Bold Move to Dominate Electric Bikes

Auto

⚡️ $45 Million EV Power-Up! Ultraviolette's Bold Move to Dominate Electric Bikes


Latest News

Russia's Sberbank Unlocks India's Stock Market for Retail Investors with New Nifty50 Fund!

Mutual Funds

Russia's Sberbank Unlocks India's Stock Market for Retail Investors with New Nifty50 Fund!

RBI Slashes Repo Rate to 5.25%! Home Loan EMIs to Plummet! Borrowers Brace for HUGE Savings & Boosted Property Market!

Real Estate

RBI Slashes Repo Rate to 5.25%! Home Loan EMIs to Plummet! Borrowers Brace for HUGE Savings & Boosted Property Market!

RBI Delivers Surprise Rate Cut! Realty & Bank Stocks Surge – Is This Your Investment Signal?

Economy

RBI Delivers Surprise Rate Cut! Realty & Bank Stocks Surge – Is This Your Investment Signal?

Vidya Wires IPO Closing Today: Over 13X Subscription & Strong GMP Signal Hot Debut!

Industrial Goods/Services

Vidya Wires IPO Closing Today: Over 13X Subscription & Strong GMP Signal Hot Debut!

Pharma Deal Alert: PeakXV Exits La Renon, Creador & Siguler Guff Invest ₹800 Cr in Healthcare Major!

Healthcare/Biotech

Pharma Deal Alert: PeakXV Exits La Renon, Creador & Siguler Guff Invest ₹800 Cr in Healthcare Major!

Massive Energy Deal: ₹10,287 Crore Secured for India's Refinery Expansion! Find Out Which Banks Are Funding This Game-Changer!

Energy

Massive Energy Deal: ₹10,287 Crore Secured for India's Refinery Expansion! Find Out Which Banks Are Funding This Game-Changer!